Hormones + Wellness by SDBotox
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Cryotherapy
- Peptide Therapy
- Red Light Therapy
La Jolla, CA
Peptide Therapy clinics in La Jolla
La Jolla has a biotech and academic medicine overlay with some of the highest peptide-clinic density in California, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across the Village, Torrey Pines, and UTC range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the UC San Diego Health, Scripps Green, and the Salk Institute ecosystem network. The scene here skews toward Scripps-trained physicians running longevity clinics near the biotech corridor. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable La Jolla clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Essential Medicine
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Ozone Therapy
Dr. Erica Oberg
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- Lyme Disease Treatment
- Peptide Therapy
MD on staff
San Diego Center for Restorative Medicine
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Shockwave Therapy
Wildcraft Naturopathic Medicine
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Integrative Health Solutions
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- IV Hydration
Hormone Upgrade & Wellness Center
- PRP Therapy
- IV Therapy
- Acne Treatment
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
MD on staff
Kadima Neuropsychiatry Institute
- Ozone Therapy
- IV Therapy
- Transcranial Magnetic Stimulation (TMS)
- Hyperbaric Oxygen Therapy (HBOT)
- Ketamine Therapy
Create Wellness, Dr. Roya Nikzad
- Vitamin IV Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Chelation Therapy
MD on staff
Essential Medicine
- Ozone Therapy
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Ketamine Therapy
- Arthritis Treatment
Regulatory context
A note on California's peptide therapy rules.
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. In 2023 and 2024 the FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list, which restricts 503A compounding pharmacies from sourcing those ingredients for patient-specific prescriptions. Section 503A covers traditional pharmacies; Section 503B covers FDA-registered outsourcing facilities operating under cGMP.
-
California Business and Professions Code Division 2 Chapter 9 (Pharmacy Law)
Governs compounding, licensure, and sourcing under the California State Board of Pharmacy. -
California Code of Regulations Title 16 Section 1735 et seq.
Sets compounding standards for sterile and non-sterile preparations. -
California Business and Professions Code Section 2052
Defines practice of medicine and limits who may prescribe or administer drugs. -
California Naturopathic Doctors Act
Grants licensed NDs limited prescriptive authority under formulary advisory committee rules.
The California State Board of Pharmacy inspects sterile compounding facilities under stringent state rules that often exceed USP 797. The Board has issued citations for sourcing non-compliant bulk ingredients and for office-use stocking that should have flowed through a 503B. Non-resident pharmacies shipping into California must hold a current non-resident permit; the Board publishes disciplinary actions and annual inspection findings. Clinics dispensing from in-office stock of compounded peptides are examined closely.